Cardiovascular gene delivery: The good road is awaiting

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Biotechnology

Background:

• Atherosclerotic cardiovascular disease remains a primary global cause of mortality.
• Current treatments, including medical, operative, and endovascular interventions, face limitations in long-term durability due to thrombotic complications and myointimal hyperplasia.
• Despite advancements, persistent complications necessitate novel therapeutic strategies.

Purpose of the Study:

• To review the technical aspects of cardiovascular gene therapy.
• To explore its applications in enhancing endothelial function, inhibiting smooth muscle cell proliferation, promoting therapeutic angiogenesis, and developing tissue-engineered vascular conduits.
• To discuss the current status of relevant clinical trials.

Main Methods:

• Review of existing literature and clinical trial data on cardiovascular gene therapy.
• Analysis of gene therapy's mechanisms for vascular repair and regeneration.
• Synthesis of information on technical challenges and therapeutic potential.

Main Results:

• Cardiovascular gene therapy demonstrates potential for improving endothelial function and inhibiting hyperplasia.
• Applications include therapeutic angiogenesis and the development of engineered vascular grafts.
• Several clinical trials are underway, indicating active research and development.

Conclusions:

• Cardiovascular gene therapy presents a significant potential to address the limitations of current interventions for atherosclerotic cardiovascular disease.
• Further research and clinical trials are crucial to fully realize its therapeutic benefits.
• This approach could lead to more durable and effective treatments for cardiovascular conditions.